Achmea Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-24,808
Closed -$5.42M – 423
2024
Q1
$5.42M Hold
24,808
– – 0.1% 206
2023
Q4
$5.64M Buy
24,808
+6,005
+32% +$1.26M 0.12% 202
2023
Q3
$3.78M Buy
18,803
+177
+1% +$37.3K 0.08% 240
2023
Q2
$3.86M Buy
18,626
+5,005
+37% +$971K 0.08% 246
2023
Q1
$2.69M Buy
13,621
+69
+0.5% +$14.2K 0.08% 263
2022
Q4
$2.57M Hold
13,552
– – 0.09% 244
2022
Q3
$2.38M Sell
13,552
-16,665
-55% -$3.41M 0.08% 247
2022
Q2
$6.08M Sell
30,217
-6,030
-17% -$1.29M 0.2% 130
2022
Q1
$8.21M Buy
+36,247
New +$8.52M 0.21% 113
2021
Q4
– Sell
-18,040
Closed -$4.36M – 377
2021
Q3
$4.36M Buy
18,040
+2,169
+14% +$547K 0.13% 212
2021
Q2
$3.76M Buy
15,871
+1,944
+14% +$443K 0.13% 221
2021
Q1
$3.05M Buy
13,927
+7,562
+119% +$1.52M 0.11% 246
2020
Q4
$1.11M Hold
6,365
– – 0.04% 388
2020
Q3
$1.03M Sell
6,365
-28,477
-82% -$4.51M 0.04% 353
2020
Q2
$4.97M Buy
34,842
+8,882
+34% +$1.23M 0.17% 119
2020
Q1
$2.82M Buy
25,960
+24,230
+1,401% +$3.49M 0.13% 128
2019
Q4
$251K Sell
1,730
-3,116
-64% -$450K 0.01% 504
2019
Q3
$700K Buy
4,846
+483
+11% +$70.5K 0.03% 395
2019
Q2
$648K Sell
4,363
-447
-9% -$62.4K 0.02% 421
2019
Q1
$632K Sell
4,810
-2,484
-34% -$306K 0.03% 376
2018
Q4
$791K Sell
7,294
-21,495
-75% -$2.88M 0.04% 343
2018
Q3
$4.29M Sell
28,789
-7,224
-20% -$1.1M 0.16% 148
2018
Q2
$5.55M Buy
36,013
+6,389
+22% +$964K 0.19% 136
2018
Q1
$4.11M Hold
29,624
– – 0.14% 176
2017
Q4
$4.06M Buy
29,624
+6,919
+30% +$914K 0.14% 182
2017
Q3
$2.94M Hold
22,705
– – 0.17% 151
2017
Q2
$3M Sell
22,705
-1,300
-5% -$159K 0.18% 154
2017
Q1
$2.96M Buy
+24,005
New +$2.84M 0.14% 192

Other funds holding LH

Achmea Investment Management's LH Position: Q2 2024 in Review

Achmea Investment Management sold out of Labcorp (LH) in Q2 2024, closing a stake of 24,808 shares — an estimated $5.42M sold.

Achmea Investment Management first reported a position in LH in Q1 2017 and held it in 28 quarters. The position peaked at $8.21M in Q1 2022. 854 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • Achmea Investment Management reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
  • Achmea Investment Management sold 24,808 Labcorp shares in Q2 2024, an estimated $5.42M.
  • Achmea Investment Management first reported a position in Labcorp in Q1 2017 and held it in 28 quarters.
  • Achmea Investment Management's Labcorp position peaked at $8.21M in Q1 2022.
  • 854 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Achmea Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.